Jennifer H.E. Baker
Jennifer H.E. Baker
Staff Scientist, BC Cancer Agency Vancouver UBC
Verified email at bccrc.ca
Title
Cited by
Cited by
Year
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy
GM Tozer, SM Ameer-Beg, J Baker, PR Barber, SA Hill, RJ Hodgkiss, ...
Advanced drug delivery reviews 57 (1), 135-152, 2005
1842005
Translational activation of HIF1α by YB-1 promotes sarcoma metastasis
AM El-Naggar, CJ Veinotte, H Cheng, TGP Grunewald, GL Negri, ...
Cancer cell 27 (5), 682-697, 2015
1542015
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenografts
JHE Baker, KE Lindquist, LA Huxham, AH Kyle, JT Sy, AI Minchinton
Clinical Cancer Research 14 (7), 2171-2179, 2008
1032008
Microregional effects of gemcitabine in HCT-116 xenografts
LA Huxham, AH Kyle, JHE Baker, LK Nykilchuk, AI Minchinton
Cancer research 64 (18), 6537-6541, 2004
832004
Metronomic gemcitabine suppresses tumour growth, improves perfusion, and reduces hypoxia in human pancreatic ductal adenocarcinoma
KKY Cham, JHE Baker, KS Takhar, JA Flexman, MQ Wong, DA Owen, ...
British journal of cancer 103 (1), 52-60, 2010
572010
Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptake
K Saatchi, P Soema, N Gelder, R Misri, K McPhee, JHE Baker, ...
Bioconjugate chemistry 23 (3), 372-381, 2012
472012
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin
JHE Baker, J Lam, AH Kyle, J Sy, T Oliver, WH Dragowska, E Ramsay, ...
Clinical Cancer Research 14 (22), 7260-7271, 2008
462008
In vivo evaluation of mucoadhesive nanoparticulate Docetaxel for intravesical treatment of non–muscle-invasive bladder cancer
C Mugabe, Y Matsui, AI So, ME Gleave, JHE Baker, AI Minchinton, ...
Clinical Cancer Research 17 (9), 2788-2798, 2011
452011
Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.
JH Baker, HC Goodpasture, HR Kuhns Jr, MG Rinaldi
Archives of pathology & laboratory medicine 113 (11), 1279-1281, 1989
451989
Loss of the Notch effector RBPJ promotes tumorigenesis
I Kulic, G Robertson, L Chang, JHE Baker, WW Lockwood, W Mok, ...
Journal of Experimental Medicine 212 (1), 37-52, 2015
412015
Targeting quiescent tumor cells via oxygen and IGF-I supplementation
AH Kyle, JHE Baker, AI Minchinton
Cancer research 72 (3), 801-809, 2012
372012
Identification of breast cancer cell subtypes sensitive to ATG4B inhibition
S Bortnik, C Choutka, HM Horlings, S Leung, JH Baker, C Lebovitz, ...
Oncotarget 7 (41), 66970, 2016
342016
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent
AH Kyle, LA Huxham, JHE Baker, HE Burston, AI Minchinton
Cancer research 63 (18), 5707-5711, 2003
332003
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration
S Maltby, S Freeman, MJ Gold, JHE Baker, AI Minchinton, MR Gold, ...
PLoS One 6 (4), e18160, 2011
292011
Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium
C Mugabe, PA Raven, L Fazli, JHE Baker, JK Jackson, RT Liggins, AI So, ...
Biomaterials 33 (2), 692-703, 2012
282012
Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism
A Patenaude, M Fuller, L Chang, F Wong, G Paliouras, R Shaw, AH Kyle, ...
Cancer research 74 (9), 2402-2411, 2014
272014
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assay
JHE Baker, LA Huxham, AH Kyle, KK Lam, AI Minchinton
Microvascular research 71 (2), 69-75, 2006
272006
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity
WH Dragowska, SA Weppler, MA Qadir, LY Wong, Y Franssen, ...
BMC cancer 11 (1), 420, 2011
232011
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts
LA Huxham, AH Kyle, JHE Baker, KL McNicol, AI Minchinton
Radiotherapy and oncology 78 (2), 138-145, 2006
232006
Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically
SC Chafe, PC McDonald, S Saberi, O Nemirovsky, G Venkateswaran, ...
Cancer immunology research 7 (7), 1064-1078, 2019
182019
The system can't perform the operation now. Try again later.
Articles 1–20